Renal Cancer
The New WHO Category of "Molecularly Defined Renal Carcinomas": Clinical and Diagnostic Features and Management Implications.
March 26, 2024
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study.
March 25, 2024
A nomogram based on TFE3 IHC results and clinical factors as a preliminary screening scheme for TFE3-rearranged renal cell carcinoma.
March 22, 2024
Designing a predictive Framework: Immune-Related Gene-Based nomogram and prognostic model for kidney renal papillary cell carcinoma.
March 21, 2024
The role of RNA-modifying proteins in renal cell carcinoma.
March 21, 2024
Evaluating Trials of Adjuvant Therapy: Is There Benefit for People With Resected Renal Cancer?
March 21, 2024
Is Adjuvant Immunotherapy Worth for All Patients with Clear-cell Renal Cell Carcinoma at High Risk of Recurrence?
March 21, 2024
Cytoreductive nephrectomy in the era of immune checkpoint inhibitors: a U.S. FDA pooled analysis.
March 20, 2024
Integrative Analysis of Germline Rare Variants in Clear and Non-clear Cell Renal Cell Carcinoma.
March 19, 2024
Prognostic factors of renal cell cancer in elderly patients: a population-based cohort study.
March 18, 2024